Should women between the ages of 25 and 30 get tested for HPV?

Basit Öğe Kaydı
dc.authorid0000-0001-8468-7038en_US
dc.authorid0000-0002-4215-1371en_US
dc.authorid0000-0001-7982-1407en_US
dc.authorid0000-0002-6941-6851en_US
dc.authorid0000-0003-4551-8439en_US
dc.contributor.authorGündüz, Reyhan
dc.contributor.authorAğaçayak, Elif
dc.contributor.authorBozbay, Özlem Polat
dc.contributor.authorİçen, Mehmet Sait
dc.contributor.authorGül, Talip
dc.contributor.authorAlabalık, Ulaş
dc.date.accessioned2022-08-23T08:12:20Z
dc.date.available2022-08-23T08:12:20Z
dc.date.issued2022en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Kadın Hastalıkları ve Doğum Ana Bilim Dalıen_US
dc.description.abstractObjectives: The aim of this study is to discuss whether performing the human papillomavirus test on women aged 25-30 in Turkey has any effect on preventing cervical cancer. It is aimed to reevaluate the screening program. Methods: A total of 400 patients between the ages of 25-30 who had the Papanicolaou smear and the human papillomavirus test were included in our study. Pap smear and the human papillomavirus test were performed again on the patients with a positive human papillomavirus test for high-risk types in accordance with the screening program. Demographical and clinical characteristics of the patients were recorded. The incidence of human papillomavirus test positivity with a high risk among patients aged 25-30, regression, and persistence ratios were calculated. Results: The incidence of human papillomavirus test positivity with a high risk among patients aged 25 to 30 was found to be 7%. Human papillomavirus persistence ratio was 17.6% and the regression ratio was 82.4%. Among patients with a positive high-risk human papillomavirus test between the ages of 25 and 30, human papillomavirus 16 was found in 47.1% of the patients. For one of our patients with a persistent human papillomavirus 16 positivity, conization was performed after the cervical biopsy. Conclusion: We believe that human papillomavirus, which plays an important role in the etiology of cervical cancer, should be screened from the age of 25. This way, we can catch and treat precursor lesions of cervical cancer at earlier ages and lower the incidence and mortality of cervical cancer.en_US
dc.identifier.citationGündüz, R., Ağaçayak, E., Bozbay, Ö. P., İçen, M. S., Gül, T., Alabalık, U. ve diğerleri. (2022). Should women between the ages of 25 and 30 get tested for HPV?. European Journal of Therapeutics, 28(2), 82-88.en_US
dc.identifier.doi10.54614/eurjther.2021.0108
dc.identifier.endpage88en_US
dc.identifier.issn2564-7784
dc.identifier.issn2564-7040
dc.identifier.issue2en_US
dc.identifier.startpage82en_US
dc.identifier.trdizinid531213
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/531213
dc.identifier.urihttps://hdl.handle.net/11468/10241
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/531213
dc.identifier.volume28en_US
dc.identifier.wosWOS:000865982100001
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.institutionauthorGündüz, Reyhan
dc.institutionauthorAğaçayak, Elif
dc.institutionauthorBozbay, Özlem Polat
dc.institutionauthorİçen, Mehmet Sait
dc.institutionauthorGül, Talip
dc.institutionauthorAlabalık, Ulaş
dc.language.isoenen_US
dc.publisherGaziantep Üniversitesi Tıp Fakültesien_US
dc.relation.ispartofEuropean Journal of Therapeutics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCervical canceren_US
dc.subjectHuman papillomavirus testen_US
dc.subjectPapanicolaou smear testen_US
dc.subjectScreening programen_US
dc.subjectYoung womenen_US
dc.titleShould women between the ages of 25 and 30 get tested for HPV?en_US
dc.titleShould women between the ages of 25 and 30 get tested for HPV?
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Should Women Between the Ages of 25 and 30 Get Tested for HPV.pdf
Boyut:
1.29 MB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Cerrahi Tıp Bilimleri Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu